Developing a vaccine to combat fungal infections

Task V31: Process Development for Panfungal Vaccine

['FUNDING_OTHER'] · ADVANCED BIOSCIENCE LABORATORIES, INC. · NIH-11087446

This study is working on a new vaccine to help protect people from tough fungal infections that don't respond well to current treatments, and it aims to make sure the vaccine is safe and effective for future use.

Quick facts

Phase['FUNDING_OTHER']
Study typeNih_funding
SexAll
SponsorADVANCED BIOSCIENCE LABORATORIES, INC. (nih funded)
Locations1 site (KENSINGTON, UNITED STATES)
Trial IDNIH-11087446 on ClinicalTrials.gov

What this research studies

This research focuses on creating a vaccine that targets various fungal infections, particularly those that are resistant to current treatments. It involves planning and optimizing the vaccine development process, ensuring compliance with manufacturing standards, and preparing for clinical trials. Patients may benefit from the development of new vaccines that could provide better protection against these infections. The research also includes regulatory support to facilitate the approval process with the FDA.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals at high risk for fungal infections, such as those with weakened immune systems or underlying health conditions.

Not a fit: Patients who are not at risk for fungal infections or those who do not have any underlying health conditions may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to effective vaccines that significantly reduce the incidence of fungal infections, especially in patients with compromised immune systems.

How similar studies have performed: Other research has shown promise in developing vaccines for infectious diseases, indicating that this approach could be successful.

Where this research is happening

KENSINGTON, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: Communicable Diseases, Infectious Disease Pathway

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.